Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:linsl2003
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Experimental studies and preliminary clinical studies have suggested that growth hormone (GH) treatment may improve cardiovascular parameters in chronic heart failure (CHF). Recombinant human GH (rhGH) has been delivered by a recombinant protein, by plasmid DNA, and by genetically engineered cells with different pharmacokinetic and physiological properties. The present study aimed to examine a new method for delivery of rhGH using genetically modified bioartificial muscles (BAMs), and investigate whether the rhGH delivered by this technique improves left ventricular (LV) function in rats with CHF.Methods Primary skeletal myoblasts were isolated from several Sprague-Dawley (SD) rats, cultured, purified, and retrovirally transduced to synthesize and secrete human rhGH, and tissue-engineered into implantable BAMs. Ligation of the left coronary artery or sham operation was performed. The rats that underwent ligation were randomly assigned to 2 groups: CHF control group (n=6) and CHF treatment group (n=6). The CHF control group received non-rhGH-secreting BAM (GFP-BAMs) transplantation, and the CHF treatment group received rhGH-secreting BAM (GH-BAMs) transplantation. Another group of rats served as the sham operation group, which was also randomly assigned to 2 subgroups: sham control group (n=6) and sham treatment group (n=6). The sham control group underwent GFP-BAM transplantation, and the sham treatment group underwent GH-BAM transplantation. GH-BAMs and GFP-BAMs were implanted subcutaneously into syngeneic rats with ligaUon of the left coronary artery or sham operation was performed. Eight weeks after the treatment,echocardiography was performed, hGH, insulin-like growth factor-1 (IGF-1) and TNF-a levels in rat serum were measured by radioimmunoassay and ELISA, and then the rats were killed and ventricular samples were subjected to immunohistochemistry. Results Primary rat myoblasts were retrovirally transduced to secrete rhGH and tissue-engineered into implantable BAMs containing parallel arrays of postmitotic myofibers. In vitro, they secreted 1 to 2 pg of bioactive rhGH per day. When implanted into syngeneic rat, GH-BAMs secreted and delivered rhGH. Eight weeks after therapy, LV ejection fraction (EF) and fractional shortening (FS) were significantly higher in CHF rats treated with GH-BAMs than in those treated with GFP-BAMs ((65.0±6.5)% vs (48.1±6.8)%, P <0.05), ((41.3±7.4)% vs (26.5±7.1)%, P <0.05). LV end-diastolic dimension (LVEDD) was significantly lower in CHF rats treated with GH-BAM than in CHF rats treated with GFP-BAM (P <0.05). The levels of serum GH and IGF-1 were increased significantly in both CHF and sham rats treated with GH-BAM. The level of serum TNF-a decreased more significantly in the CHF treatment group than in the CHF control group.Conclusions rhGH significantly improves LV function and prevents cardiac remodeling in rats with CHF. Genetically modified tissue-engineered bioartificial muscle provides a method delivering recombinant protein for the treatment of heart failure.
其他文献
目的采用超声斑点追踪成像(STI)技术评价腺苷药物后适应对兔心肌缺血再灌注损伤的保护作用。方法42只健康兔随机均分为3组:单纯缺血再灌注组(IR)、缺血后适应组(IPost)、腺苷药物后适应组(ATP-PPost)。制备心肌缺血再灌注模型,于冠状动脉阻断前、阻断后45 min、再灌注120 min行超声心动图检查;冠状动脉阻断后45 min每组随机抽取2只兔,其余兔实验结束后行病理学检查。结果①病
期刊
目的应用二维斑点追踪技术评价肾动脉交感神经消融对肺动脉高压犬心脏收缩功能的影响。方法本实验犬分3组:对照组7只,肺高压(PAH)组8只,肾动脉交感神经消融(PAH+RSD)组7只。PAH组及PAH+RSD组静脉注射脱氢野百合碱,建立肺动脉高压模型,且PAH+RSD组进一步消融双侧肾动脉交感神经,而对照组及PAH组做假手术处理。分别于建模前和建模8周后观察比格犬的血压变化及心脏指标变化。测量左室侧壁
用于商务交往中的包装,其生产和检验用的非自动衡器与自动衡器,都有检定条例.由于国家规程的欧洲、国际一致,也涉及到德国检定法律规定.本文要说明立法的现实情况.尤其要阐述
期刊
本文采用常规工艺,采用上海、广州两地的原材料制备出90MPa~100MPa,初始坍落度为(20±2)cm,2小时坍落度为17cm以上的大流动度高强混凝土.深入研究了掺合料、减水剂、砂率等因
通过对S700K提速道岔锁钩与锁闭铁卡阻故障现象的分析,找出锁闭铁倒角弧度存在的缺陷及提速道岔调整不当等原因,提出了改进建议。 Based on the analysis of the failure of
目的观察西药联用中药消溃平汤剂治疗消化性溃疡的疗效及护理。方法随机将85例消化性溃疡患者分为2组,治疗组采用西药联用中药消溃平汤剂治疗,配合饮食指导及整体护理;对照组采